Sars-Cov-2 and risk of antiviral drug resistance. | Ir J Med Sci;191(5): 2367-2368, 2022 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Sars-Cov-2 and risk of antiviral drug resistance.

Vitiello, Antonio.

Vitiello A; Clinical Pharmacologist, Pharmaceutical Department Usl Umbria 1, Via XIV Settembre-75, Perugia, Italy.

Ir J Med Sci ; 191(5): 2367-2368, 2022 10.

Article in English | MEDLINE | ID: covidwho-1491360

Subject(s)

COVID-19; SARS-CoV-2; Antiviral Agents/pharmacology; Antiviral Agents/therapeutic use; Drug Resistance, Viral; Humans

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Ir J Med Sci Year: 2022 Document Type: Article Affiliation country: S11845-021-02820-y

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Ir J Med Sci Year: 2022 Document Type: Article Affiliation country: S11845-021-02820-y